Stimulation of the farnesoid X receptor promotes M2 macrophage polarization

Stimulation of the farnesoid X receptor promotes M2 macrophage polarization

FXR is a key molecule that modulates anti-inflammatory activity in the intestinal-liver axis. Although FXR has pleiotropic functions including regulation of liver inflammation and activation of macrophages, it remains unclear whether it is involved in macrophage polarization. In this paper we demons...

Full description

Bibliographic Details
Main Authors:	Thiranut Jaroonwitchawan, Hideki Arimochi, Yuki Sasaki, Chieko Ishifune, Hiroyuki Kondo, Kunihiro Otsuka, Shin-ichi Tsukumo, Koji Yasutomo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Frontiers in Immunology
Subjects:	farnesoid X receptor macrophage cell differentiation inflammation tissue repair
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1065790/full

Similar Items

Distinct Roles of IL-1β and IL-18 in NLRC4-Induced Autoinflammation
by: Yuki Sasaki, et al.
Published: (2020-10-01)

Blockade of the CXCR3/CXCL10 axis ameliorates inflammation caused by immunoproteasome dysfunction
by: Yuki Sasaki, et al.
Published: (2022-04-01)

Markers of Memory CD8 T Cells Depicting the Effect of the BNT162b2 mRNA COVID-19 Vaccine in Japan
by: Hiroyuki Kondo, et al.
Published: (2022-04-01)

Regulation of CD8+ T Cells and Antitumor Immunity by Notch Signaling
by: Shin-ichi Tsukumo, et al.
Published: (2018-01-01)

CD98 Heavy Chain Is a Potent Positive Regulator of CD4+ T Cell Proliferation and Interferon-γ Production In Vivo.
by: Takeshi Kurihara, et al.
Published: (2015-01-01)

Farnesoid X Receptor, Bile Acid Metabolism, and Gut Microbiota
by: Hideki Mori, et al.
Published: (2022-07-01)

Bile Acids Elevated in Chronic Periaortitis Could Activate Farnesoid-X-Receptor to Suppress IL-6 Production by Macrophages
by: Shan Cao, et al.
Published: (2021-04-01)

Taurocholic Acid and Glycocholic Acid Inhibit Inflammation and Activate Farnesoid X Receptor Expression in LPS-Stimulated Zebrafish and Macrophages
by: Xutao Ge, et al.
Published: (2023-02-01)

Design and lyophilization of lipid nanoparticles for mRNA vaccine and its robust immune response in mice and nonhuman primates
by: Yuta Suzuki, et al.
Published: (2022-12-01)

Abrogation of Rbpj attenuates experimental autoimmune uveoretinitis by inhibiting IL-22-producing CD4+ T cells.
by: Zaied Ahmed Bhuyan, et al.
Published: (2014-01-01)

Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes
by: Apollinariya V. Bogolyubova, et al.
Published: (2017-12-01)

Natural Products Targeting Liver X Receptors or Farnesoid X Receptor
by: Jianglian She, et al.
Published: (2022-01-01)

Farnesoid X Receptor Expression in Microscopic Colitis: A Potential Role in Disease Etiopathogenesis
by: Joana Torres, et al.
Published: (2017-10-01)

The Farnesoid X Receptor as a Master Regulator of Hepatotoxicity
by: Magdalena Rausch, et al.
Published: (2022-11-01)

The regulation of tissue-specific farnesoid X receptor on genes and diseases involved in bile acid homeostasis
by: Dong Xiang, et al.
Published: (2023-12-01)

Xanthohumol improves cognition in farnesoid X receptor-deficient mice on a high-fat diet
by: Payel Kundu, et al.
Published: (2022-11-01)

Role of farnesoid X receptor and bile acids in alcoholic liver disease
by: Sharon Manley, et al.
Published: (2015-03-01)

Restraint stress promotes nonalcoholic steatohepatitis by regulating the farnesoid X receptor/NLRP3 signaling pathway
by: Yang Fan, et al.
Published: (2023-11-01)

Farnesoid X receptor knockout protects brain against ischemic injury through reducing neuronal apoptosis in mice
by: Hui-Min Shan, et al.
Published: (2020-05-01)

Saffron offers hepatoprotection via up-regulation of hepatic farnesoid-X-activated receptors in a rat model of acetaminophen-induced hepatotoxicity
by: Vahid Jamshidi, et al.
Published: (2021-11-01)

Peroxisome proliferator-activated receptors, farnesoid X receptor, and dual modulating drugs in hypertension
by: John D. Imig
Published: (2023-06-01)

Loss of Farnesoid X receptor (FXR) accelerates dysregulated glucose and renal injury in db/db mice
by: Yuxiang Qiu, et al.
Published: (2023-09-01)

Norcholic Acid Promotes Tumor Progression and Immune Escape by Regulating Farnesoid X Receptor in Hepatocellular Carcinoma
by: Yihang Gong, et al.
Published: (2021-11-01)

PRIMIS: design of a pivotal, randomized, phase 3 study evaluating the safety and efficacy of the nonsteroidal farnesoid X receptor agonist cilofexor in noncirrhotic patients with primary sclerosing cholangitis
by: Michael Trauner, et al.
Published: (2023-03-01)

Structural basis of the farnesoid X receptor/retinoid X receptor heterodimer on inverted repeat DNA
by: Longying Jiang, et al.
Published: (2023-01-01)

Alpha-linolenic acid inhibits hepatocellular carcinoma cell growth through Farnesoid X receptor/β-catenin signaling pathway
by: Shu Feng, et al.
Published: (2022-08-01)

Upregulation of microRNA-23b-3p induced by farnesoid X receptor regulates the proliferation and apoptosis of osteosarcoma cells
by: Bin Wu, et al.
Published: (2019-11-01)

Gypenosides ameliorate high-fat diet-induced non-alcoholic steatohepatitis via farnesoid X receptor activation
by: Hongshan Li, et al.
Published: (2022-08-01)

Farnesoid X receptor regulates forkhead Box O3a activation in ethanol-induced autophagy and hepatotoxicity
by: Sharon Manley, et al.
Published: (2014-01-01)

Biliary cirrhosis-induced cardiac abnormality in rats: Interaction between Farnesoid-X-activated receptors and the cardiac uncoupling proteins 2 and 3
by: Gholamreza Bayat, et al.
Published: (2022-01-01)

Arbutin Alleviates the Liver Injury of α-Naphthylisothiocyanate-induced Cholestasis Through Farnesoid X Receptor Activation
by: Peijie Wu, et al.
Published: (2021-12-01)

Xanthohumol ameliorates Diet-Induced Liver Dysfunction via Farnesoid X Receptor-Dependent and Independent Signaling
by: Ines L. Paraiso, et al.
Published: (2021-04-01)

Mangrove Tirucallane- and Apotirucallane-Type Triterpenoids: Structure Diversity of the C-17 Side-Chain and Natural Agonists of Human Farnesoid/Pregnane–X–Receptor
by: Zhong-Ping Jiang, et al.
Published: (2018-12-01)

The Pathophysiology of Farnesoid X Receptor (FXR) in the GI Tract: Inflammation, Barrier Function and Innate Immunity
by: Kemp M. Anderson, et al.
Published: (2021-11-01)

TO901317 regulating apolipoprotein M expression mediates via the farnesoid X receptor pathway in Caco-2 cells
by: Berggren-Söderlund Maria, et al.
Published: (2011-11-01)

Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer
by: Mengjiao Zhou, et al.
Published: (2022-10-01)

Regulation of Chromatin Accessibility by the Farnesoid X Receptor Is Essential for Circadian and Bile Acid Homeostasis In Vivo
by: Haider M. Hassan, et al.
Published: (2022-12-01)

The Status of Bile Acids and Farnesoid X Receptor in Brain and Liver of Rats with Thioacetamide-Induced Acute Liver Failure
by: Anna Maria Czarnecka, et al.
Published: (2020-10-01)

Farnesoid X receptor agonist tropifexor attenuates cholestasis in a randomised trial in patients with primary biliary cholangitis
by: Christoph Schramm, et al.
Published: (2022-11-01)

Role of farnesoid X receptor in establishment of ontogeny of phase-I drug metabolizing enzyme genes in mouse liver
by: Lai Peng, et al.
Published: (2016-09-01)